Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that ...

Deciphera stock rocketed to a three-year high Monday after Ono Pharmaceutical agreed to buy it for $2.4 billion.Please watch ...

Cancer immunotherapy, which leverages the body's immune system to target tumors, has emerged as a pivotal strategy in ...

In the assessment of 12-month price targets, analysts unveil insights for Deciphera Pharmaceuticals, presenting an average ...

Using Pepper Bio’s transomics platform, COMPASS, the company was able to identify CDK4 and CDK6 as potentially important targets in treating HCC. Pepper Bio then tested lerociclib in preclinical ...

A research team led by Professor Haruhisa Inoue (Department of Cell Growth and Differentiation) derived iPS cells (iPSC) from ...

Deciphera specializes in kinase drug discovery, where kinases are enyzmes that help regulate cellular function.

SignalChem Biotech will bring exclusive expertise in enzyme production to Sino Biologicals' existing technology platforms.

Deciphera Pharmaceuticals Inc’s DCPH share price has surged by 72.56%, which has investors questioning if this is right time to sell.

Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML ...

A groundbreaking study has recognized the cGAS-STING signaling pathway as a formidable ally in the immune system's battle ...